Dan Puckett - 09 Jun 2026 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Reporting relationship: Director
Issuer ticker: PRCT
Reported as of: 09 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 16:34:50 UTC
Prior SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Stone, Attorney-in-Fact for Dan Puckett

Key filing fact

Dan Puckett filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 10 Jun 2026.

Key facts

This page summarizes Dan Puckett's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 16:34.

Change

Previous filing in this sequence was filed on 09 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001602773 Primary reporting owner

PUCKETT DAN

Relationship: Director
Address: 150 BAYTECH DR., SAN JOSE
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Dan Puckett
Signature date: 10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT transaction

Common Stock

Award

Transaction value
Shares: +3,315
Change %: +61%
Price: $0.000000^*
Shares after: 8,791
Date: 09 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRCT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +5,853
Change %
Price: $0.000000^*
Shares after: 5,853
Date: 09 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,853
Exercise price: $28.78
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Footnote F2

The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.